Dror Avni
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- RNA and protein synthesis mechanisms
- RNA Research and Splicing
- RNA modifications and cancer
- Extracellular vesicles in disease
- Circular RNAs in diseases
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- MicroRNA in disease regulation 8
- Immunology 10
- interferon and immune responses 4
- Psoriasis: Treatment and Pathogenesis 4
- Co-authors
- Oded Meyuhas (6 shared papers)Yechezkel Sidi (21 shared papers)Shoshana Levy (1 shared paper)Robert P. Perry (1 shared paper)Narayanan Hariharan (1 shared paper)Raya Leibowitz‐Amit (12 shared papers)Fabrizio Loreni (2 shared papers)Aviv Barzilai (7 shared papers)
- Journals
- Molecular and Cellular Biology (2 papers)International Journal of Molecular Sciences (2 papers)PLoS ONE (2 papers)Oncogene (2 papers)Nature Communications (2 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Dror Avni
38 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 461
- Molecular Biology 1.4k
- Parasitology 131
- Immunology 318
- Oncology 282
Countries citing papers authored by Dror Avni
This map shows the geographic impact of Dror Avni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dror Avni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dror Avni more than expected).
Fields of papers citing papers by Dror Avni
This network shows the impact of papers produced by Dror Avni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dror Avni. The network helps show where Dror Avni may publish in the future.
Co-authors
The 25 scholars most cited alongside Dror Avni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 296 | |
| 2 | 2002 | 238 | |
| 3 | 2017 | 153 | |
| 4 | 1994 | 131 | |
| 5 | 2012 | 122 | |
| 6 | 2011 | 121 | |
| 7 | 1997 | 107 | |
| 8 | 2003 | 102 | |
| 9 | 2019 | 76 | |
| 10 | 2015 | 64 | |
| 11 | 2016 | 61 | |
| 12 | 1999 | 60 | |
| 13 | 2014 | 50 | |
| 14 | Overexpression of initiation factor eIF-4E does not relieve the translational repression of ribosomal protein mRNAs in quiescent cells. | 1995 | 46 |
| 15 | 2017 | 45 | |
| 16 | 2018 | 40 | |
| 17 | 2018 | 37 | |
| 18 | 1994 | 31 | |
| 19 | 2021 | 30 | |
| 20 | 2018 | 29 |
About Dror Avni
Dror Avni is a scholar working on Cancer Research, Immunology, Molecular Biology, Oncology and Parasitology, having authored 39 papers that have together received 2.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), RNA Research and Splicing (7 papers), RNA Interference and Gene Delivery (5 papers), RNA modifications and cancer (5 papers), RNA and protein synthesis mechanisms (5 papers), interferon and immune responses (4 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Extracellular vesicles in disease (4 papers). The work is most often cited by research in Cancer Research (461 citations), Molecular Biology (1.4k citations), Parasitology (131 citations), Immunology (318 citations) and Oncology (282 citations). Dror Avni has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Oded Meyuhas, Yechezkel Sidi, Shoshana Levy, Robert P. Perry, Narayanan Hariharan, Raya Leibowitz‐Amit, Fabrizio Loreni, Aviv Barzilai, Galya Lerman and Tal Meningher. Their work appears in journals such as Molecular and Cellular Biology, International Journal of Molecular Sciences, PLoS ONE, Oncogene and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.